Cytokinetics, Incorporated · NASDAQ:CYTK
Vanguard Capital Management LLC reported a 5.21% stake in Cytokinetics, Incorporated (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 29, 2026
Vanguard Capital Management LLC reported a 5.21% stake in Cytokinetics, Incorporated, 6,422,042 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.21%
- Shares
- 6,422,042
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.21% | 6,422,042 |
Source
Related
- Cytokinetics, Incorporated
- Vanguard Capital Management LLC
- Cytokinetics, Incorporated shareholders
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026